These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
290 related articles for article (PubMed ID: 3924487)
1. Pharmacokinetic and clinical aspects of intensified subcutaneous insulin therapy. Lauritzen T Dan Med Bull; 1985 May; 32(2):104-18. PubMed ID: 3924487 [No Abstract] [Full Text] [Related]
2. Subcutaneous use of regular human insulin (Novo): pharmacokinetics and continuous insulin infusion therapy. Sonnenberg GE; Kemmer FW; Cüppers HJ; Berger M Diabetes Care; 1983; 6 Suppl 1():35-9. PubMed ID: 6343035 [TBL] [Abstract][Full Text] [Related]
3. New modes of insulin administration: do they have a role in clinical diabetes? Rizza RA Ann Intern Med; 1986 Jul; 105(1):126-9. PubMed ID: 3087254 [No Abstract] [Full Text] [Related]
5. [Treatment of insulin-dependent diabetes by continuous sub-cutaneous insulin perfusion]. Berger M; Sonnenberg E; Chantelau EA; Best F Journ Annu Diabetol Hotel Dieu; 1984; ():175-82. PubMed ID: 6443218 [No Abstract] [Full Text] [Related]
6. Replacement treatment with insulin in diabetes mellitus: problems and promise. Dupre J; Champion MC; Rodger NW Clin Invest Med; 1982; 5(2-3):109-19. PubMed ID: 6749365 [TBL] [Abstract][Full Text] [Related]
7. [Risks and side effects of intensified insulin therapy]. Honegger R; Spinas GA Wien Med Wochenschr; 1997; 147(9):226-30. PubMed ID: 9281237 [TBL] [Abstract][Full Text] [Related]
8. Intensified insulin therapy--is there anything left to argue? Amiel SA Diabet Med; 1997 Nov; 14(11):909-10. PubMed ID: 9400913 [No Abstract] [Full Text] [Related]
9. Frequency of diabetic ketoacidosis and hypoglycemic coma during treatment with continuous subcutaneous insulin infusion. Audit of medical care. Bending JJ; Pickup JC; Keen H Am J Med; 1985 Dec; 79(6):685-91. PubMed ID: 3934967 [TBL] [Abstract][Full Text] [Related]
10. [Treatment with insulin pump during hospital care should be questioned. Three cases illustrate the risk of ketoacidosis]. Gubrianska D; Moberg E; Palmér M Lakartidningen; 2009 Aug 5-18; 106(32-33):1967-8. PubMed ID: 19764373 [No Abstract] [Full Text] [Related]
11. [Continuous subcutaneous insulin infusion therapy. Prerequisites, indications and risks]. Sonnenberg GE; Spraul M; Chantelau EA; Berger M Dtsch Med Wochenschr; 1985 Nov; 110(48):1859-64. PubMed ID: 3933943 [No Abstract] [Full Text] [Related]
17. [Modern insulin therapy]. Waldhäusl W; Czerwenka-Howorka K Wien Med Wochenschr; 1985 Apr; 135(6-7):151-9. PubMed ID: 3923721 [No Abstract] [Full Text] [Related]
18. [Present role of continuous subcutaneous insulin infusion (CSII) by insulin pump in the treatment of diabetes mellitus]. Pfützner A; Berger S; Spinas G Schweiz Med Wochenschr; 2000 Dec; 130(48):1854-61. PubMed ID: 11132530 [TBL] [Abstract][Full Text] [Related]
19. [Current technics in the improvement of insulin treatment]. Spinas GA; Berger W Ther Umsch; 1989 Oct; 46(10):715-21. PubMed ID: 2683184 [TBL] [Abstract][Full Text] [Related]
20. [Guanidine derivatives in the treatment of patients with diabetes mellitus]. Liashko KIa; Severova TM Sov Med; 1974 Jun; 37(6):70-5. PubMed ID: 4211010 [No Abstract] [Full Text] [Related] [Next] [New Search]